Esophagogastric Junction Cancer

• CLINICAL_TRIALS trial_result · 2026-07-02
  Clinical Trial Update: Ramucirumab Plus FOLFIRI Versus Ramucirumab Plus Paclitaxel in Patients With Advanced or Metastatic Gastric Cancer, Who Failed One Prior Line of Palliative Chemotherapy [Phase 2, Phase 3]

  Clinical trial comparing ramucirumab plus FOLFIRI versus ramucirumab plus paclitaxel in advanced or metastatic gastric cancer after one prio…

• CLINICAL_TRIALS trial_result · 2025-07-16
  Clinical Trial Update: The Efficacy and Safety of HIPEC Combined With PD-1 and SOX Chemotherapy for the Translational Treatment of GC or EGJC With PM [Phase 2]

  Phase 2 trial evaluating the efficacy and safety of HIPEC combined with a PD-1 inhibitor and S-1 plus oxaliplatin chemotherapy in metastatic…

• CLINICAL_TRIALS trial_result · 2025-06-18
  Clinical Trial Update: Perioperative Chemoimmunotherapy With/Without Preoperative Chemoradiation for Locally Advanced Gastric Cancer [Phase 2]

  A Phase 2 trial of perioperative chemoimmunotherapy with or without preoperative chemoradiation for locally advanced gastric cancer was term…

• CLINICAL_TRIALS trial_result · 2025-05-16
  Clinical Trial Update: A Study of PET Scans With the Radioactive Tracer 18F-BMS-986229 in Patients With Esophageal, Stomach, or Gastroesophageal Junction Cancer

  A completed clinical trial evaluating PET imaging with the radiotracer 18F-BMS-986229 in patients with cancers of the esophagus, stomach, or…

• CLINICAL_TRIALS trial_result · 2025-02-19
  Clinical Trial Update: Heated Intraperitoneal Chemotherapy and Gastrectomy for Gastric Cancer With Positive Peritoneal Cytology [Phase 2]

  This document reports the completion of a Phase 2 trial evaluating heated intraperitoneal chemotherapy plus gastrectomy for gastric cancer w…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2024-09-04
  Clinical Trial Update: ADP-A2M4CD8 in HLA-A2+ Subjects With MAGE-A4 Positive Esophageal or Esophagogastric Junction Cancers (SURPASS-2) [Phase 2]

  Phase 2 SURPASS-2 trial evaluating ADP-A2M4CD8 in HLA-A2+ patients with MAGE-A4 positive esophageal or esophagogastric junction cancers was …

• CLINICAL_TRIALS trial_result · 2024-01-10
  Clinical Trial Update: Perioperative Adebrelimab and Chemotherapy in Esophageal and Esophagogastric Junction Carcinoma [Phase 2]

  A Phase 2 clinical trial update evaluating perioperative Adebrelimab plus chemotherapy for esophageal and esophagogastric junction carcinoma…

• CLINICAL_TRIALS trial_result · 2023-12-12
  Clinical Trial Update: Intraperitoneal and Intravenous Paclitaxel Chemotherapy With Oral Capecitabine for Gastric Adenocarcinoma With Peritoneal Carcinomatosis [Phase 2]

  Phase 2 study evaluating combined intraperitoneal/intravenous paclitaxel with oral capecitabine for gastric adenocarcinoma with peritoneal c…

• CLINICAL_TRIALS trial_result · 2022-05-09
  Clinical Trial Update: An Investigational Study of Immunotherapy Combinations With Chemotherapy in Patients With Gastric or Gastroesophageal Junction (GEJ) Cancers [Phase 2]

  A Phase 2 study evaluating immunotherapy in combination with chemotherapy for gastric cancer and gastroesophageal junction cancers; the tria…

• CLINICAL_TRIALS trial_result · 2020-07-21
  Clinical Trial Update: Phase II/III Study Comparing Chemoradiotherapy With Radiotherapy in Elderly Patients With Esophageal or Esophagogastric Cancer - 3JECROG P-01 [Phase 2, Phase 3]

  Phase II/III study comparing chemoradiotherapy with radiotherapy in elderly patients with esophageal or esophagogastric cancer has completed…

• CLINICAL_TRIALS trial_result · 2020-01-29
  Clinical Trial Update: A Randomized, Double Blind Study Evaluating Paclitaxel With and Without RAD001 in Patients With Gastric Carcinoma After Prior Chemotherapy [Phase 3]

  Phase 3 randomized, double-blind trial comparing paclitaxel with and without RAD001 in advanced gastric cancer after prior chemotherapy (com…

• CLINICAL_TRIALS trial_result · 2020-01-06
  Clinical Trial Update: A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism [Phase 2]

  A Phase 2 randomized open-label study comparing subcutaneous dalteparin to direct oral anticoagulants for cancer-associated venous thromboem…

• CLINICAL_TRIALS trial_result · 2011-11-10
  Clinical Trial Update: Taxanes or Platinum in Combination With Capecitabine Followed by Capecitabine Alone as First Line Treatment for Patients With Advanced Adenocarcinoma of Stomach or Esophagogastric Junction [Phase 3]

  A Phase 3 clinical trial evaluating taxanes or platinum in combination with capecitabine, followed by capecitabine alone, as first-line trea…